Pharmacologic management of aneurysms

JH Lindeman, JS Matsumura - Circulation research, 2019 - Am Heart Assoc
Current management of aortic aneurysms relies exclusively on prophylactic operative repair
of larger aneurysms. Great potential exists for successful medical therapy that halts or …

Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm

B Liu, DJ Granville, J Golledge… - American Journal of …, 2020 - journals.physiology.org
Aortic aneurysm is a permanent focal dilation of the aorta. It is usually an asymptomatic
disease but can lead to sudden death due to aortic rupture. Aortic aneurysm-related …

Therapies for thoracic aortic aneurysms and acute aortic dissections: old controversies and new opportunities

DM Milewicz, F Ramirez - Arteriosclerosis, Thrombosis, and …, 2019 - Am Heart Assoc
Thoracic aortic aneurysms that progress to acute aortic dissections are often fatal. Thoracic
aneurysms have been managed with treatment with β-adrenergic blocking agents (β …

[HTML][HTML] Pathophysiology and therapeutics of thoracic aortic aneurysm in Marfan syndrome

K Asano, A Cantalupo, L Sedes, F Ramirez - Biomolecules, 2022 - mdpi.com
About 20% of individuals afflicted with thoracic aortic disease have single-gene mutations
that predispose the vessel to aneurysm formation and/or acute aortic dissection often without …

[HTML][HTML] Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in …

HHC Yang, JM Kim, E Chum, C van Breemen… - The Journal of thoracic …, 2010 - Elsevier
OBJECTIVE: Losartan potassium (INN losartan), an antihypertensive drug, has been shown
to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of …

Medical treatment of aortic aneurysms in Marfan syndrome and other heritable conditions

CHA Jost, M Greutmann, HM Connolly… - Current Cardiology …, 2014 - ingentaconnect.com
Thoracic aortic aneurysms can be triggered by genetic disorders such as Marfan syndrome
(MFS) and related aortic diseases as well as by inflammatory disorders such as giant cell …

[HTML][HTML] The mechanism and therapy of aortic aneurysms

J Gao, H Cao, G Hu, Y Wu, Y Xu, H Cui, HS Lu… - Signal transduction and …, 2023 - nature.com
Aortic aneurysm is a chronic aortic disease affected by many factors. Although it is generally
asymptomatic, it poses a significant threat to human life due to a high risk of rupture …

Update on clinical trials of losartan with and without β-blockers to block aneurysm growth in patients with Marfan syndrome: a review

MAH Bowman, KA Eagle, DM Milewicz - JAMA cardiology, 2019 - jamanetwork.com
Importance Thoracic aortic aneurysms leading to acute aortic dissections are a major cause
of morbidity and mortality despite significant advances in surgical treatment, which remains …

Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem

RW Thompson - Current opinion in cardiology, 1996 - journals.lww.com
Abdominal aortic aneurysms (AAAs) are an increasingly common and potentially lethal
condition. Surgical repair of AAA is now yet performed quite safely, yet ruptured AAAs still …

Novel mechanisms of abdominal aortic aneurysms

H Lu, DL Rateri, D Bruemmer, LA Cassis… - Current atherosclerosis …, 2012 - Springer
Abdominal aortic aneurysms (AAAs) are a common but asymptomatic disease that has high
susceptibility to rupture. Current therapeutic options are limited to surgical procedures …